Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 9
1966 11
1967 13
1968 28
1969 21
1970 41
1971 42
1972 30
1973 22
1974 42
1975 55
1976 47
1977 54
1978 83
1979 81
1980 86
1981 87
1982 127
1983 132
1984 134
1985 154
1986 175
1987 182
1988 175
1989 225
1990 263
1991 275
1992 297
1993 289
1994 311
1995 374
1996 362
1997 366
1998 399
1999 507
2000 550
2001 624
2002 691
2003 743
2004 828
2005 943
2006 1080
2007 1099
2008 1183
2009 1287
2010 1562
2011 1633
2012 1661
2013 1738
2014 1743
2015 1952
2016 1821
2017 1738
2018 1808
2019 1933
2020 2120
2021 2257
2022 2084
2023 1936
2024 1107

Search Results

37,626 results

Results by year

Filters applied: . Clear all
Page 1
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Elez E, Cruz FM, Wyrwicz L, Stroyakovskiy D, Pápai Z, Poureau PG, Liposits G, Cremolini C, Bondarenko I, Modest DP, Benhadji KA, Amellal N, Leger C, Vidot L, Tabernero J; SUNLIGHT Investigators. Prager GW, et al. N Engl J Med. 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963. N Engl J Med. 2023. PMID: 37133585 Clinical Trial.
Treatment of Metastatic Colorectal Cancer: ASCO Guideline.
Morris VK, Kennedy EB, Baxter NN, Benson AB 3rd, Cercek A, Cho M, Ciombor KK, Cremolini C, Davis A, Deming DA, Fakih MG, Gholami S, Hong TS, Jaiyesimi I, Klute K, Lieu C, Sanoff H, Strickler JH, White S, Willis JA, Eng C. Morris VK, et al. J Clin Oncol. 2023 Jan 20;41(3):678-700. doi: 10.1200/JCO.22.01690. Epub 2022 Oct 17. J Clin Oncol. 2023. PMID: 36252154 Free PMC article.
Current Targeted Therapy for Metastatic Colorectal Cancer.
Ohishi T, Kaneko MK, Yoshida Y, Takashima A, Kato Y, Kawada M. Ohishi T, et al. Int J Mol Sci. 2023 Jan 15;24(2):1702. doi: 10.3390/ijms24021702. Int J Mol Sci. 2023. PMID: 36675216 Free PMC article. Review.
Immunotherapy, Inflammation and Colorectal Cancer.
Lichtenstern CR, Ngu RK, Shalapour S, Karin M. Lichtenstern CR, et al. Cells. 2020 Mar 4;9(3):618. doi: 10.3390/cells9030618. Cells. 2020. PMID: 32143413 Free PMC article. Review.
Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy.
Álvarez-Varela A, Novellasdemunt L, Barriga FM, Hernando-Momblona X, Cañellas-Socias A, Cano-Crespo S, Sevillano M, Cortina C, Stork D, Morral C, Turon G, Slebe F, Jiménez-Gracia L, Caratù G, Jung P, Stassi G, Heyn H, Tauriello DVF, Mateo L, Tejpar S, Sancho E, Stephan-Otto Attolini C, Batlle E. Álvarez-Varela A, et al. Nat Cancer. 2022 Sep;3(9):1052-1070. doi: 10.1038/s43018-022-00402-0. Epub 2022 Jun 30. Nat Cancer. 2022. PMID: 35773527 Free article.
Nano-enabled colorectal cancer therapy.
Pan Q, Fan X, Xie L, Wu D, Liu R, Gao W, Luo K, He B, Pu Y. Pan Q, et al. J Control Release. 2023 Oct;362:548-564. doi: 10.1016/j.jconrel.2023.09.014. Epub 2023 Sep 9. J Control Release. 2023. PMID: 37683732 Review.
Third-Line Therapy in Metastatic Colorectal Cancer.
van de Haar J, Valeri N, Voest EE. van de Haar J, et al. N Engl J Med. 2023 Jul 13;389(2):190. doi: 10.1056/NEJMc2306486. N Engl J Med. 2023. PMID: 37437152 No abstract available.
Colorectal cancer.
Paty PB, Garcia-Aguilar J. Paty PB, et al. J Surg Oncol. 2022 Oct;126(5):881-887. doi: 10.1002/jso.27079. J Surg Oncol. 2022. PMID: 36087081 Review.
37,626 results
You have reached the last available page of results. Please see the User Guide for more information.